March 24 (Reuters) - Karyopharm Therapeutics said on Tuesday its therapy led to significant reduction in spleen size in a late-stage study of patients with a rare blood cancer, meeting only one of its ...
March 24 (Reuters) - Karyopharm Therapeutics said on Tuesday its therapy for patients with a rare blood cancer showed a reduction in spleen size in a late-stage trial, meeting one of the two main ...
Splenomegaly is one of the characteristic signs of an overactive spleen. It can cause platelets to pool inside of your spleen and cause thrombocytopenia. Thrombocytopenia is when you have a low ...
Karyopharm Therapeutics said on Tuesday its oncology therapy showed a statistically significant improvement in spleen ...
Gabriel Vilardi will miss an unknown amount of time recovering from an enlarged spleen, Rick Bowness told reporters on Friday. The ailment was discovered while Vilardi was being evaluated for a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results